Advertisement

Design and Planning of Sustainable Vaccine Supply Chain

  • Mafalda Ivo de Carvalho
  • David Ribeiro
  • Ana Paula Barbosa-PovoaEmail author
Chapter
Part of the Lecture Notes in Logistics book series (LNLO)

Abstract

Sustainable supply chains are nowadays-targeted systems by both academics as well as industrial organizations. The Vaccines Supply Chain (VSC) being of utmost importance because of its great relevance in the world health, should be designed and operated in an optimized form not only aiming to guarantee high service levels at minimum costs but also considering environmental and social concerns. This study addresses such goal and proposes a Multi-Objective and multi-period Mixed Integer Linear Programming (MO-MILP) model for the simultaneous design and planning of sustainable VSC. The three dimensions of the Triple Bottom Line (TBL)—economic, environmental and social are modelled considering respectively the maximization of the Net Present Value (NPV); minimization of environmental impacts; and maximization of social impacts. The model is applied to a representative European supply chain case study, based in a European company. The outcomes obtained with the different scenarios studied clearly show how strategic and tactical decision-making impacts on key performance indicators in a VSC. Again, by the results, it becomes clear the existence of trade-offs between the sustainability dimensions considered and the importance of using multi-objective approach to find feasible and sustainable solutions.

Keywords

Vaccine supply chain Sustainability Optimization Design and planning 

Notes

Acknowledgements

The authors would like to acknowledge the financial support from FCT to the project PTDC/EGE-OGE/28071/2017.

References

  1. Amaro, A., & Barbosa-Póvoa, A. P. (2008). Planning and scheduling of industrial supply chains with reverse flows: A real pharmaceutical case study. Computers & Chemical Engineering, 32, 2606–2625.Google Scholar
  2. Assi, T. M., Brown, S. T., Kone, S., Norman, B. A., Djibo, A., Connor, D. L., & et al. (2013). Removing the regional level from the Niger vaccine supply chain. Vaccine, 31(26), 2828–2834.Google Scholar
  3. Barbosa-Póvoa, A. P. (2014). Process supply chains management—Where are we? Where to go next? Frontiers in Energy Research-Process and Energy Systems Engineering, 2, 23.Google Scholar
  4. Barbosa-Póvoa, A. P., & Pinto, J. M. (2018). Challenges and perspectives of process systems engineering in supply chain management. Computer Aided Chemical Engineering, 44, 87–96.CrossRefGoogle Scholar
  5. Barbosa-Póvoa, A. P., Silva, C., & Carvalho, A. (2018). Opportunities and challenges in sustainable supply chain: An operations research perspective. European Journal of Operational Research, 268(2), 399–431.CrossRefGoogle Scholar
  6. Bloom, D. E., Canning, D., & Weston, M. (2005). The value of vaccination. World Economics-Henley on Thames, 6(3), 15.Google Scholar
  7. Brealey, R. A., Myers, S. C., & Allen, F. (2014). Principles of corporate finance (11th ed.). New York, NY: McGraw-Hill/Irwin.Google Scholar
  8. Cardoso, S. R., Barbosa-Póvoa, A. P., & Relvas, S. (2013). Design and planning of supply chains with integration of reverse logistics activities under demand uncertainty. European Journal of Operational Research, 226(3), 436–445.CrossRefGoogle Scholar
  9. Chick, S. E., Mamani, H., & Simchi-Levi, D. (2008). Supply chain coordination and influenza vaccination. Operations Research, 56(6), 1493–1506.CrossRefGoogle Scholar
  10. Deloitte. (2016). Global health care outlook. Deloitte, 2–8. Retrieved May 2018, from https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-Care/gx-lshc-2016-health-care-outlook.pdf.
  11. Deo, S., & Corbett, C. J. (2009). Cournot competition under yield uncertainty: The case of the U.S. influenza vaccine market. Manufacturing & Service Operations Management, 11(4), 563–576.Google Scholar
  12. Dubey, R., Gunasekaran, A., Childe, S. J., Papadopoulos, T., & Wamba, S. F. (2017). World class sustainable supply chain management: Critical review and further research directions. The International Journal of Logistics Management, 28(2), 332–362.CrossRefGoogle Scholar
  13. Duijzer, E., Van Jaarsveld, W. L., & Dekker, R. (2018). Literature review—The vaccine supply chain. European Journal of Operational Research, 268(1), 174–192.CrossRefGoogle Scholar
  14. EFPIA. (2018). The pharmaceutical industry in figures. Retrieved October 2018, from https://efpia.eu/media/361960/efpia-pharmafigures2018_v07-hq.pdf.
  15. Elkington, J. (1998). Cannibals with Forks: The triple bottom line of the 21st century. Stoney Creek: New Society Publishers.Google Scholar
  16. European Commission. (2018). Sustainable development in the European Union: Monitoring report on progress towards the SDGS in an EU context. Luxembourg: Office for Official Publications of the European Union.Google Scholar
  17. Fawcett, S. E., Magnan, G. M., & McCarter, M. W. (2008). A three-stage implementation model for supply chain collaboration. Journal of Business Logistics, 29(1), 93–112.CrossRefGoogle Scholar
  18. Gatica, G., Papageorgiou, L. G., & Shah, N. (2003). Capacity planning under uncertainty for the pharmaceutical industry. Chemical Engineering Research and Design, 81(6), 665–678.CrossRefGoogle Scholar
  19. Goedkoop, M., Heijungs, R., Huijbregts, M., Schryver, A. D., Struijs, J., & Van Zelm, R. (2009). ReCiPe 2008—A life cycle impact assessment method which comprises harmonised category indicators at the midpoint and the endpoint level. The Hague: Ministry of VROM.Google Scholar
  20. Goedkoop, M., Heijungs, R., Huijbregts, M., Schryver, A. D., Struijs, J., & Van Zelm, R. (2016). ReCiPe 2016—A life cycle impact assessment method which comprises harmonised category indicators at the midpoint and the endpoint level. Report I: Characterization. The Hague: Ministry of VROM.Google Scholar
  21. Hauschild, M. Z., & Huijbregts, M. A. J. (2015). Introducing life cycle impact assessment. In M. Z. Hauschild & M. A. J. Huijbregts (Eds.), Life cycle impact assessment (pp. 1–16). Springer Science + Business Media. (LCA Compendium—The Complete World of Life Cycle Assessment).Google Scholar
  22. Hovav, S., & Tsadikovich, D. (2015). A network flow model for inventory management and distribution of influenza vaccines through a healthcare supply chain. Operations Research for Health Care, 5, 49–62.CrossRefGoogle Scholar
  23. IFPMA. (2014). The complex journey of a vaccine. IFPMA. Retrieved May 2018, from http://www.ifpma.org/wp-content/uploads/2016/01/TheComplexJourneyofaVaccinePRINT-EN.pdf.
  24. IFPMA (2016). The complex journey of a vaccine—Part II. IFPMA. Retrieved May 2018, from http://www.ifpma.org/wp-content/uploads/2016/01/IFPMA-ComplexJourney-FINAL-Digital.pdf.
  25. ISO (2006). International Organization for Standardization. ISO 14040 Stand. Retrieved September 2018, from www.iso.org.
  26. Joint Reseacrh Center. (2011). ILCD Handbook—Recommendations for life cycle impact assessment in the European context. Luxemburg: Publications Office of the European Union.Google Scholar
  27. Kaufmann, J. R., Miller, R., & Cheyne, J. (2011). Vaccine supply chains need to be better funded and strengthened, or lives will be at risk. Health Affairs, 30(6), 1113–1121.CrossRefGoogle Scholar
  28. Kumar, S., Dieveney, E., & Dieveney, A. (2009). Reverse logistic process control measures for the pharmaceutical industry supply chain. International Journal of Productivity and Performance Management, 58(2), 188–204.CrossRefGoogle Scholar
  29. Lee, B. Y., Connor, D. L., Wateska, A. R., Norman, B. A., Rajgopal, J., Cakouros, B. E., & et al. (2015). Landscaping the structures of GAVI country vaccine supply chains and testing the effects of radical redesign. Vaccine33(36), 4451–4458.Google Scholar
  30. Lemmens, S., Decouttere, C., Vandaele, N., & Bernuzzi, M. (2016). A review of integrated supply chain network design models: Key issues for vaccine supply chains. Chemical Engineering Research and Design, 109, 366–384.CrossRefGoogle Scholar
  31. Market Realist. (2015). An easier way to understand the pharma industry. Market Realist. Retrieved June 2018, from https://marketrealist.com/2015/01/global-needs-drive-growth-pharmaceutical-industry.
  32. Mehralian, G., Moosivand, A., Emadi, S., & Asgharian, R. (2017). Developing a coordination framework for pharmaceutical supply chain: using analytical hierarchy process. International Journal of Logistics Systems and Management, 26(3), 277–293.CrossRefGoogle Scholar
  33. Melo, M. T., Nickel, S., & Saldanha-da-Gama, F. (2009). Facility location and supply chain management—A review. European Journal of Operational Research, 196(2), 401–412.CrossRefGoogle Scholar
  34. Mota, B., Gomes, M. I., Carvalho, A., & Barbosa-Póvoa, A. P. (2015). Towards supply chain sustainability: economic, environmental and social design and planning. Journal of Cleaner Production, 105, 14–27.Google Scholar
  35. Mota, B., Gomes, M. I., Carvalho, A., & Barbosa-Póvoa, A. P. (2017). Sustainable supply chains: An integrated modeling approach under uncertainty. Omega, 000, 1–26.Google Scholar
  36. Mota, B., Carvalho, A., Gomes, M. I., & Barbosa-Póvoa, A. P. (2018). Green supply chain design and planning: The importance of decision integration in optimization models. In A. I. F. Vaz, J. P. Almeida, J. F. Oliveira & A. A. Pinto (Eds.), Proceedings in mathematics and statistics (Vol. 223, pp. 249–257). Springer International Publishing.Google Scholar
  37. Mousazadeh, M., Torabi, S. A., & Zahiri, B. (2015). A robust possibilistic programming approach for pharmaceutical supply chain network design. Computers & Chemical Engineering, 82, 115–128.CrossRefGoogle Scholar
  38. Mvundura, M., Lorenson, K., Chweya, A., Kigadye, R., Bartholomew, K., Makame, M., & Otieno, A. (2015). Estimating the costs of the vaccine supply chain and service delivery for selected districts in Kenya and Tanzania. Vaccine, 33(23), 2697–2703.Google Scholar
  39. Pagell, M., & Shevchenko, A. (2014). Why research in sustainable supply chain management should have no future. Journal of Supply Chain Management, 50(1), 44–55.CrossRefGoogle Scholar
  40. Papageorgiou, L. G., Rotstein, G. E., & Shah, N. (2001). Strategic supply chain optimization for the pharmaceutical industries. Industrial and Engineering Chemistry Research, 40(1), 275–286.CrossRefGoogle Scholar
  41. Pfizer Inc. (2017). Pfizer 2017 annual review. Pfizer. Retrieved June 2018, from https://www.pfizer.com/files/investors/financial_reports/annual_reports/2017/assets/pdf/pfizer-2017-annual-review.pdf.
  42. Reklaitis, G. (2017). Prospects and challenges for process systems engineering in healthcare. Computer Aided Chemical Engineering, 40, 3–7.CrossRefGoogle Scholar
  43. Reuter, C., Foerstl, K., Hartmann, E., & Blome, C. (2010). Sustainable global supplier management: the role of dynamic capabilities in achieving competitive advantage. Journal of Supply Chain Management, 46(2–3), 45–63.Google Scholar
  44. Saif, A., & Elhedhli, S. (2016). Cold supply chain design with environmental considerations: A simulation-optimization approach. European Journal of Operational Research, 251(1), 274–287.CrossRefGoogle Scholar
  45. Saki, P., & Ebrahimnejad, S. (2015). An integrated approach for measuring the performance of suppliers in the pharmaceutical industry: A case study. International Journal of Logistics Systems and Management, 22(3), 267–295.CrossRefGoogle Scholar
  46. Salema, M. I. G., Barbosa-Povoa, A. P., & Novais, A. Q. (2010). Simultaneous design and planning of supply chains with reverse flows: A generic modelling framework. European Journal of Operational Research, 203, 336–349.Google Scholar
  47. Schmidt, G., & Wilhelm, W. E. (2000). Strategic, tactical and operational decisions in multi-national logistics networks: A review and discussion of modelling issues. International Journal of Production Research, 38(7), 1501–1523.CrossRefGoogle Scholar
  48. Seuring, S., & Müller, M. (2008). From a literature review to a conceptual framework for sustainable supply chain management. Journal of Cleaner Production, 16(15), 1699–1710.CrossRefGoogle Scholar
  49. Shah, N. (2004). Pharmaceutical supply chains: Key issues and strategies for optimisation. Computers & Chemical Engineering, 28(6), 929–941.CrossRefGoogle Scholar
  50. Sousa, R. T., Liu, S., Papageorgiou, L. G., & Shah, N. (2011). Global supply chain planning for pharmaceuticals. Chemical Engineering Research and Design, 89(11), 2396–2409.CrossRefGoogle Scholar
  51. World Health Organization & PATH. (2011). Developing a vision for immunization supply systems in 2020 landscape analysis summaries. WHO & PATH. Retrieved July 2018, from http://www.path.org/publications/detail.php?i=1964.
  52. Yadav, P., Lydon, P., Oswald, J., Dicko, M., & Zaffran, M. (2014). Integration of vaccine supply chains with other health commodity supply chains: A framework for decision making. Vaccine, 32(50), 6725–6732.CrossRefGoogle Scholar
  53. Zaffran, M., Vandelaer, J., Kristensen, D., Melgaard, B., Yadav, P., Antwi-Agyei, K. O., et al. (2013). The imperative for stronger vaccine supply and logistics systems. Vaccine, 31, B73–B80.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Mafalda Ivo de Carvalho
    • 1
  • David Ribeiro
    • 1
  • Ana Paula Barbosa-Povoa
    • 1
    Email author
  1. 1.Centre for Management Studies (CEG-IST), Instituto Superior Técnico, University of LisbonLisbonPortugal

Personalised recommendations